HR 1734 · 118th Congress 2023–2025, ended

TRANQ Research Act of 2023

Introduced Mar 23, 2023 Originated House Became Public Law 118-23 Sponsor Mike Collins R-GA

Latest action · Dec 19, 2023 Became Public Law No: 118-23.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

IntroducedMar 23, 2023
Passed HouseMay 11, 2023
Passed SenateJun 22, 2023
To the PresidentDec 14, 2023
Became lawDec 19, 2023Public Law 118-23

Summary

Version

Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023

This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances.

In particular, NIST must support

basic measurement science and research;
near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance);
strategies and voluntary best practices for handling, transporting, and analyzing such substances; and
collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities.

Additionally, the Government Accountability Office must conduct a study on the capabilities of the federal government to detect, identify, and otherwise respond to threats of new psychoactive substances, such as xylazine.

Recorded votes 1

Newest first. Open one to see how every member voted.

Roll call	Question	Result	Date
House 212	On Motion to Suspend the Rules and Pass, as Amended	Passed425–0	May 11, 2023

Cosponsors 25

Members who signed on, in the order they did. Signatures ran from Mar 23, 2023 to May 5, 2023; 18 are original cosponsors, there from the day it was introduced.

Seat	Cosponsor		Signed on
R-NY	Brandon Williams	Original	Mar 23, 2023
R-TX	Brian Babin	Original	Mar 23, 2023
R-NY	Claudia Tenney	Original	Mar 23, 2023
R-AL	Dale W. Strong	Original	Mar 23, 2023
D-MD	David J. Trone	Original	Mar 23, 2023
D-NC	Deborah K. Ross	Original	Mar 23, 2023
R-AR	Eric A. "Rick" Crawford	Original	Mar 23, 2023
D-IL	Eric Sorensen	Original	Mar 23, 2023
R-OK	Frank D. Lucas	Original	Mar 23, 2023
R-CA	Jay Obernolte	Original	Mar 23, 2023
D-VA	Jennifer L. McClellan	Original	Mar 23, 2023
D-CA	Kevin Mullin	Original	Mar 23, 2023
R-CA	Mike Garcia	Original	Mar 23, 2023
R-TX	Randy K. Weber, Sr.	Original	Mar 23, 2023
R-NJ	Thomas H. Kean, Jr.	Original	Mar 23, 2023
D-NC	Valerie P. Foushee	Original	Mar 23, 2023
D-CO	Yadira Caraveo	Original	Mar 23, 2023
D-CA	Zoe Lofgren	Original	Mar 23, 2023
D-NC	Jeff Jackson		Mar 28, 2023
R-OH	Max L. Miller		Mar 28, 2023
R-FL	Scott Franklin		Mar 28, 2023
D-OH	Emilia Strong Sykes		Mar 30, 2023
D-MI	Haley M. Stevens		Mar 30, 2023
D-PA	Summer L. Lee		Apr 19, 2023
D-NH	Chris Pappas		May 5, 2023

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

Chamber	Committee	What it did
House	Science, Space, and Technology Committee	Referred Mar 23, 2023Markup Mar 29, 2023Reported May 5, 2023

Actions 24

Everything that happened, newest first.

Dec 19, 2023Signed by President.
Dec 19, 2023Became Public Law No: 118-23.
Dec 14, 2023Presented to President.
Dec 4, 2023Mr. Lucas moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H6087-6089)
Dec 4, 2023DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and agree to the Senate amendment to H.R. 1734.

Show all 24 actions

In the Congressional Record 6

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

Where	In the Record	Members	Date
House	Debate and remarks H6087–H6089Amendments H6087	Frank D. Lucas R-OK, Mike Collins R-GA, Yadira Caraveo D-CO, Zoe Lofgren D-CA	Dec 4, 2023
House	Debate and remarks H3214	Mike Collins R-GA	Jul 12, 2023
Senate	Debate and remarks S2250Amendments S2249, S2250	Charles E. Schumer D-NY, Maria Cantwell D-WA (amendment), Ted Cruz R-TX (amendment)	Jun 22, 2023
House	Recorded votes H2295enact	—	May 11, 2023
House	Debate and remarks H2149–H2151Text printed H2149	Haley M. Stevens D-MI, Max L. Miller R-OH, Mike Collins R-GA, Yadira Caraveo D-CO, Zoe Lofgren D-CA	May 9, 2023

Show all 6 days

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Committee report

H. Rept. 118-50

Congressional Budget Office cost estimate

May 5, 2023H.R. 1734, TRANQ Research ActAs ordered reported by the House Committee on Science, Space, and Technology on March 29, 2023

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: U.S. Constitution, Article I, Section 8, Clause 18: ``The Congress shall have Power . . . To make all Laws which shall be necessary and proper for carrying into Execution the forgoing Powers, and all other Powers vested by this Constitution in the Government of the United States, or in any Department or Officer thereof.'' The single subject of this legislation is: To require the National Institute of Standards and Technology to advance science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern.

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 53, March 23, 2023, page H1410.

CRS reports 5

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 5

Products on other subjects that cite it, usually among other measures.

Product	Title	Kind	Published
R45948	The Controlled Substances Act (CSA): A Legal Overview for the 119th Congress	Report	Jan 22, 2025
LSB11202	Xylazine and the Controlled Substances Act: Legal Considerations for Congress	Insight	Jul 19, 2024
R48127	Natural Gas Reliability: Issues for Congress	Report	Jul 15, 2024
IF12682	Electoral College Overview	Resource	Jun 5, 2024
IN12172	Changes to IRS Funding in the Debt Limit Deal Archived	Insight	Jul 19, 2023

Amendments 1

Amendments offered to this bill.

Amendment	Description	Offered by	Status
SA 139	in the nature of a substitute.	Ted Cruz R-TXfor Charles E. Schumer	Amendment SA 139 agreed to in Senate by Unanimous Consent.

Related bills 1

Companion bills and other measures the record links to this one.

Bill	Title	Relationship	Latest action
S 1280	TRANQ Research Act of 2023	Related bill	Dec 13, 2023

Titles 15

Every title it has carried, official and short, at each stage.

Official Title as Introduced: To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.
Short Titles as Passed Senate: TRANQ Research Act of 2023; Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023
Short Titles as Enacted: Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023; TRANQ Research Act of 2023
Short Title(s) as Introduced: Testing, Rapid Analysis, and Narcotic Quality Research Act; TRANQ Research Act
Short Title(s) as Reported to House: TRANQ Research Act; Testing, Rapid Analysis, and Narcotic Quality Research Act
Short Title(s) as Passed House: TRANQ Research Act; Testing, Rapid Analysis, and Narcotic Quality Research Act
Short Titles from ENR (Enrolled) bill text: Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023; TRANQ Research Act of 2023
Short Title(s) from Engrossed Amendment Senate bill text: Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023; TRANQ Research Act of 2023

Subjects

Assigned by the Library of Congress. Policy area: Science, Technology, Communications.

Text 6

Each version as it was printed, newest first.

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.